These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24292889)

  • 41. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
    Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
    Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice.
    Sell GL; Xin W; Cook EK; Zbinden MA; Schaffer TB; O'Meally RN; Cole RN; Margolis SS
    Sci Rep; 2021 Sep; 11(1):19414. PubMed ID: 34593829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuronal Proteomic Analysis of the Ubiquitinated Substrates of the Disease-Linked E3 Ligases Parkin and Ube3a.
    Martinez A; Ramirez J; Osinalde N; Arizmendi JM; Mayor U
    Biomed Res Int; 2018; 2018():3180413. PubMed ID: 29693004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioinformatics Analyses of the Transcriptome Reveal Ube3a-Dependent Effects on Mitochondrial-Related Pathways.
    Panov J; Simchi L; Feuermann Y; Kaphzan H
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired Neurite Contact Guidance in Ubiquitin Ligase E3a (Ube3a)-Deficient Hippocampal Neurons on Nanostructured Substrates.
    Tonazzini I; Meucci S; Van Woerden GM; Elgersma Y; Cecchini M
    Adv Healthc Mater; 2016 Apr; 5(7):850-62. PubMed ID: 26845073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Towards an understanding of Angelman syndrome in mice studies.
    Yang X
    J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV-1 Impairment via UBE3A and HIV-1 Nef Interactions Utilizing the Ubiquitin Proteasome System.
    Pyeon D; Rojas VK; Price L; Kim S; Meharvan S; Park IW
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31783587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cobalamins Function as Allosteric Activators of an Angelman Syndrome-Associated UBE3A/E6AP Variant.
    Müller F; Jansen J; Offensperger F; Eichbichler D; Stengel F; Scheffner M
    Chembiochem; 2024 May; 25(10):e202400184. PubMed ID: 38573110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes.
    Mabb AM; Judson MC; Zylka MJ; Philpot BD
    Trends Neurosci; 2011 Jun; 34(6):293-303. PubMed ID: 21592595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes.
    Martínez-Noël G; Luck K; Kühnle S; Desbuleux A; Szajner P; Galligan JT; Rodriguez D; Zheng L; Boyland K; Leclere F; Zhong Q; Hill DE; Vidal M; Howley PM
    J Mol Biol; 2018 Mar; 430(7):1024-1050. PubMed ID: 29426014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ubiquitin ligase Ariadne-1 regulates neurotransmitter release via ubiquitination of NSF.
    Ramírez J; Morales M; Osinalde N; Martínez-Padrón I; Mayor U; Ferrús A
    J Biol Chem; 2021; 296():100408. PubMed ID: 33581113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angelman syndrome: advancing the research frontier of neurodevelopmental disorders.
    Philpot BD; Thompson CE; Franco L; Williams CA
    J Neurodev Disord; 2011 Mar; 3(1):50-6. PubMed ID: 21484597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRL4Mahj E3 ubiquitin ligase promotes neural stem cell reactivation.
    Ly PT; Tan YS; Koe CT; Zhang Y; Xie G; Endow S; Deng WM; Yu F; Wang H
    PLoS Biol; 2019 Jun; 17(6):e3000276. PubMed ID: 31170139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A genome-wide enhancer/suppressor screen for Dube3a interacting genes in Drosophila melanogaster.
    Hope KA; McGinn A; Reiter LT
    Sci Rep; 2019 Feb; 9(1):2382. PubMed ID: 30787400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angelman syndrome protein UBE3A interacts with primary microcephaly protein ASPM, localizes to centrosomes and regulates chromosome segregation.
    Singhmar P; Kumar A
    PLoS One; 2011; 6(5):e20397. PubMed ID: 21633703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A proteasomal partner goes missing in Angelman syndrome.
    Huibregtse JM
    J Biol Chem; 2018 Nov; 293(47):18400-18401. PubMed ID: 30470726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions.
    Khatri N; Man HY
    Front Mol Neurosci; 2019; 12():109. PubMed ID: 31114479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of UBE3A Protein in CSF and Extracellular Space of the Hippocampus Suggest a Potential Novel Function in Synaptic Plasticity.
    Dodge A; Willman J; Willman M; Nenninger AW; Morrill NK; Lamens K; Greene H; Weeber EJ; Nash KR
    Autism Res; 2021 Apr; 14(4):645-655. PubMed ID: 33474832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angelman Syndrome Due to UBE3A Gene Mutation.
    Goswami JN; Sahu JK; Singhi P
    Indian J Pediatr; 2018 May; 85(5):390-391. PubMed ID: 29250725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.